COPD

Stronger abdominal muscles could reduce fatigue and increase health-related quality of life for patients with chronic obstructive pulmonary disease (COPD) who have chronic coughing.

Certain groups of patients with chronic obstructive pulmonary disease (COPD) may see more benefits from adding a combination of aclidinium bromide and formoterol to their existing treatment, according to research conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG).

Specialists agree that a condition unofficially known as asthma-COPD overlap syndrome (ACOS) exists, according to a survey completed by Marc Miravitlles, MD, and colleagues. The participants were 26 specialists in either asthma or chronic obstructive pulmonary disease (COPD practicing in Spain. They first completed a structured questionnaire, and then attended an in-person work meeting that followed the Metaplan technique.

People with pulmonary arterial hypertension may benefit from initial combination therapy with ambrisentan and tadalafil, according to a recent study published in the New England Journal of Medicine

Patients with chronic obstructive pulmonary disease (COPD) often display inhibited mitochondrial protein pathways, according to a study published in the Journal of Clinical Investigation.

A medical phenomenon called asthma-COPD overlap syndrome (ACOS) – is closer to being understood by researchers.

For patients hospitalized for chronic obstructive pulmonary disease (COPD) related complications, failing to see pulmonologists after discharge was found to increase readmission risk threefold, researchers reported in CHEST.

Chronic obstructive pulmonary disease (COPD) may be able to be treated with a newly validated drug target.

Patients with chronic obstructive pulmonary disease (COPD) who do not follow-up with their pulmonologists after being discharged from the hospital face a significantly higher risk of being readmitted than those who do.

Oxygen therapy patients with diagnosed COPD often are of lower socioeconomic status and female, according to a report published in PLOS One.

Readmissions for patients with COPD can be prevented with a multi-faceted approach, a study finds.

Mature Type 1 and Type 2 airway cells are able to repair and regenerate lung tissue regardless of cell type, according to researchers from Penn and Duke.

Walking, an activity taken for granted by many, doesn't come easy for patients with chronic obstructive pulmonary disease (COPD). Dutch researchers are trying to change this, and have assessed the most beneficial walking aids, identifying which types work best during daily outdoor walking.

A statement released by the Radiological Society of North America (RSNA) endorsed the use of magnetic resonance imaging (MRI), computed tomography (CT), and other imaging techniques for improving the quality of life and treatment of chronic obstructive pulmonary disease (COPD) patients.

Regardless of disease progression, German researchers reported that physical activity decreases over time in patients with chronic obstructive pulmonary disease (COPD), further worsening their condition.

COPD research should focus on patient-centered outcomes according to a joint statement from the American Thoracic Society and the European Respiratory Society.

Roflumilast, the first selective phosphodiesterase 4 inhibitor approved for the treatment of chronic obstructive pulmonary disease (COPD), could actually become less effective with prolonged exposure.

Postoperative pulmonary complications (PPCs) after major abdominal surgery are common, with risk increasing with patient age. Major abdominal surgeries alter and disrupt diaphragmatic dysfunction, which has been proven causative of PPCs.

Oxygen therapy is associated with burn injuries in patients with COPD, according to new findings.

On average, Aboriginal Australians have a lower forced vital lung capacity compared to the rest of the population, a phenomenon that was formerly attributed to COPD, according to a study published in Respirology.

Investigators at Toronto Western Hospital deemed an existing - but not widely used - augmentation therapy effective at treating genetically-motivate emphysema.

Researchers say over-expression of key proteins may cause the overproduction of mucus that is observed in airway diseases.